Reference SummaryLee S, PLoS One 2010;5(6):e10995
Title |
Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice. | ||||||||||
Authors |
Lee S; Donehower LA; Herron AJ; Moore DD; Fu L | ||||||||||
Journal |
PLoS One | ||||||||||
Volume |
5 | ||||||||||
Issue |
6 | ||||||||||
Year |
2010 | ||||||||||
Pages |
e10995 | ||||||||||
Abstract |
BACKGROUND: Cell proliferation in all rapidly renewing mammalian tissues follows a circadian rhythm that is often disrupted in advanced-stage tumors. Epidemiologic studies have revealed a clear link between disruption of circadian rhythms and cancer development in humans. Mice lacking the circadian genes Period1 and 2 (Per) or Cryptochrome1 and 2 (Cry) are deficient in cell cycle regulation and Per2 mutant mice are cancer-prone. However, it remains unclear how circadian rhythm in cell proliferation is generated in vivo and why disruption of circadian rhythm may lead to tumorigenesis. METHODOLOGY/PRINCIPAL FINDINGS: Mice lacking Per1 and 2, Cry1 and 2, or one copy of Bmal1, all show increased spontaneous and radiation-induced tumor development. The neoplastic growth of Per-mutant somatic cells is not controlled cell-autonomously but is dependent upon extracellular mitogenic signals. Among the circadian output pathways, the rhythmic sympathetic signaling plays a key role in the central-peripheral timing mechanism that simultaneously activates the cell cycle clock via AP1-controlled Myc induction and p53 via peripheral clock-controlled ATM activation. Jet-lag promptly desynchronizes the central clock-SNS-peripheral clock axis, abolishes the peripheral clock-dependent ATM activation, and activates myc oncogenic potential, leading to tumor development in the same organ systems in wild-type and circadian gene-mutant mice. CONCLUSIONS/SIGNIFICANCE: Tumor suppression in vivo is a clock-controlled physiological function. The central circadian clock paces extracellular mitogenic signals that drive peripheral clock-controlled expression of key cell cycle and tumor suppressor genes to generate a circadian rhythm in cell proliferation. Frequent disruption of circadian rhythm is an important tumor promoting factor. | ||||||||||
Links |
J:161808 – MGI References 20539819 – National Library of Medicine/PubMed |
||||||||||
Strain Notes
|
|||||||||||
| Strain | Model Name | Treatment Agent(s) | Organ Affected | Frequency | Model Details |
|---|---|---|---|---|---|
| C57BL/6 | Bone osteosarcoma | Bone |
0 |
||
| C57BL/6 | Bone osteosarcoma |
|
Bone |
0 |
|
| C57BL/6 | Bone osteosarcoma |
|
Bone |
3.7 |
|
| B6.129-Bmal1tm1Bra/+ | Bone osteosarcoma | Bone |
0 |
||
| B6.129-Bmal1tm1Bra/+ | Bone osteosarcoma |
|
Bone |
0 |
|
| B6.129-Bmal1tm1Bra | Bone osteosarcoma | Bone |
0 |
||
| B6.129-Bmal1tm1Bra | Bone osteosarcoma |
|
Bone |
0 |
|
| B6.129-Bmal1tm1Bra | Bone osteosarcoma |
|
Bone |
0 |
|
| B6.129-Per2tm1Ccl | Bone osteosarcoma | Bone |
0 |
||
| B6.129-Per2tm1Ccl | Bone osteosarcoma |
|
Bone |
3.03 |
|
| B6.129-Per2tm1Ccl | Bone osteosarcoma |
|
Bone |
5.71 |
|
| C57BL/6-Cry1tm1Asn | Bone osteosarcoma | Bone |
0 |
||
| C57BL/6-Cry1tm1Asn | Bone osteosarcoma |
|
Bone |
4.76 |
|
| C57BL/6-Cry1tm1Asn Cry2tm1Asn | Bone osteosarcoma | Bone |
0 |
||
| C57BL/6-Cry1tm1Asn Cry2tm1Asn | Bone osteosarcoma |
|
Bone |
3.33 |
|
| C57BL/6-Cry1tm1Asn Cry2tm1Asn | Bone osteosarcoma |
|
Bone |
6.06 |
|
| C57BL/6-Per1tm1Brd Per2tm1Brd | Bone osteosarcoma | Bone |
0 |
||
| C57BL/6-Per1tm1Brd Per2tm1Brd | Bone osteosarcoma |
|
Bone |
2.13 |
|
| C57BL/6-Per1tm1Brd Per2tm1Brd | Bone osteosarcoma |
|
Bone |
4.08 |
|
| B6.129S7-Trp53tm1Brd | Bone osteosarcoma |
|
Bone |
observed |
|
| C57BL/6-Cry1tm1Asn Cry2tm1Asn | Intestine tumor |
|
Intestine |
observed |
|
| C57BL/6-Per1tm1Brd Per2tm1Brd | Intestine tumor |
|
Intestine |
observed |
|
| C57BL/6-Cry1tm1Asn Cry2tm1Asn | Kidney tumor |
|
Kidney |
observed |
|
| C57BL/6-Per1tm1Brd Per2tm1Brd | Kidney tumor |
|
Kidney |
observed |
|
| C57BL/6 | Leukocyte lymphoma | Leukocyte |
5.56 |
||
| C57BL/6 | Leukocyte lymphoma |
|
Leukocyte |
10.23 |
|
| C57BL/6 | Leukocyte lymphoma |
|
Leukocyte |
27.78 |
|
| C57BL/6 | Leukocyte lymphoma |
|
Salivary gland |
observed |
|
| B6.129-Bmal1tm1Bra/+ | Leukocyte lymphoma | Leukocyte |
12.9 |
||
| B6.129-Bmal1tm1Bra/+ | Leukocyte lymphoma |
|
Leukocyte |
33.33 |
|
| B6.129-Bmal1tm1Bra/+ | Leukocyte lymphoma |
|
Leukocyte |
observed |
|
| B6.129-Bmal1tm1Bra/+ | Leukocyte lymphoma |
|
Salivary gland |
observed |
|
| B6.129-Bmal1tm1Bra | Leukocyte lymphoma | Leukocyte |
0 |
||
| B6.129-Bmal1tm1Bra | Leukocyte lymphoma |
|
Leukocyte |
8.33 |
|
| B6.129-Bmal1tm1Bra | Leukocyte lymphoma |
|
Leukocyte |
7.69 |
|
| B6.129-Bmal1tm1Bra | Leukocyte lymphoma |
|
Salivary gland |
observed |
|
| B6.129-Per2tm1Ccl | Leukocyte lymphoma | Leukocyte |
13.33 |
||
| B6.129-Per2tm1Ccl | Leukocyte lymphoma |
|
Leukocyte |
33.33 |
|
| B6.129-Per2tm1Ccl | Leukocyte lymphoma |
|
Leukocyte |
40 |
|
| C57BL/6-Cry1tm1Asn | Leukocyte lymphoma | Leukocyte |
10 |
||
| C57BL/6-Cry1tm1Asn | Leukocyte lymphoma |
|
Leukocyte |
23.81 |
|
| C57BL/6-Cry1tm1Asn Cry2tm1Asn | Leukocyte lymphoma | Leukocyte |
13.33 |
||
| C57BL/6-Cry1tm1Asn Cry2tm1Asn | Leukocyte lymphoma |
|
Leukocyte |
23.33 |
|
| C57BL/6-Cry1tm1Asn Cry2tm1Asn | Leukocyte lymphoma |
|
Leukocyte |
36.36 |
|
| C57BL/6-Cry1tm1Asn Cry2tm1Asn | Leukocyte lymphoma |
|
Salivary gland |
observed |
|
| C57BL/6-Per1tm1Brd Per2tm1Brd | Leukocyte lymphoma | Leukocyte |
17.5 |
||
| C57BL/6-Per1tm1Brd Per2tm1Brd | Leukocyte lymphoma |
|
Leukocyte |
36.17 |
|
| C57BL/6-Per1tm1Brd Per2tm1Brd | Leukocyte lymphoma |
|
Leukocyte |
38.78 |
|
| B6.129S7-Trp53tm1Brd | Leukocyte lymphoma |
|
Leukocyte |
observed |
|
| C57BL/6 | Liver hepatocellular carcinoma |
|
Liver |
observed |
|
| B6.129-Bmal1tm1Bra/+ | Liver hepatocellular carcinoma |
|
Liver |
observed |
|
| B6.129-Per2tm1Ccl | Liver hepatocellular carcinoma | Liver |
observed |
||
| B6.129-Per2tm1Ccl | Liver hepatocellular carcinoma |
|
Liver |
observed |
|
| C57BL/6-Cry1tm1Asn Cry2tm1Asn | Liver hepatocellular carcinoma | Liver |
observed |
||
| C57BL/6-Cry1tm1Asn Cry2tm1Asn | Liver hepatocellular carcinoma |
|
Liver |
observed |
|
| C57BL/6-Per1tm1Brd Per2tm1Brd | Liver hepatocellular carcinoma | Liver |
observed |
||
| C57BL/6-Per1tm1Brd Per2tm1Brd | Liver hepatocellular carcinoma |
|
Liver |
observed |
|
| C57BL/6 | Liver hepatocellular tumor | Liver |
1.11 |
||
| C57BL/6 | Liver hepatocellular tumor |
|
Liver |
2.27 |
|
| C57BL/6 | Liver hepatocellular tumor |
|
Liver |
7.41 |
|
| B6.129-Bmal1tm1Bra/+ | Liver hepatocellular tumor | Liver |
3.23 |
||
| B6.129-Bmal1tm1Bra/+ | Liver hepatocellular tumor |
|
Liver |
7.41 |
|
| B6.129-Bmal1tm1Bra | Liver hepatocellular tumor | Liver |
0 |
||
| B6.129-Bmal1tm1Bra | Liver hepatocellular tumor |
|
Liver |
0 |
|
| B6.129-Bmal1tm1Bra | Liver hepatocellular tumor |
|
Liver |
0 |
|
| B6.129-Per2tm1Ccl | Liver hepatocellular tumor | Liver |
6.67 |
||
| B6.129-Per2tm1Ccl | Liver hepatocellular tumor |
|
Liver |
9.09 |
|
| B6.129-Per2tm1Ccl | Liver hepatocellular tumor |
|
Liver |
14.29 |
|
| C57BL/6-Cry1tm1Asn | Liver hepatocellular tumor | Liver |
5.0 |
||
| C57BL/6-Cry1tm1Asn | Liver hepatocellular tumor |
|
Liver |
9.52 |
|
| C57BL/6-Cry1tm1Asn Cry2tm1Asn | Liver hepatocellular tumor | Liver |
6.67 |
||
| C57BL/6-Cry1tm1Asn Cry2tm1Asn | Liver hepatocellular tumor |
|
Liver |
13.33 |
|
| C57BL/6-Cry1tm1Asn Cry2tm1Asn | Liver hepatocellular tumor |
|
Liver |
18.18 |
|
| C57BL/6-Per1tm1Brd Per2tm1Brd | Liver hepatocellular tumor | Liver |
10 |
||
| C57BL/6-Per1tm1Brd Per2tm1Brd | Liver hepatocellular tumor |
|
Liver |
17.02 |
|
| C57BL/6-Per1tm1Brd Per2tm1Brd | Liver hepatocellular tumor |
|
Liver |
24.49 |
|
| B6.129S7-Trp53tm1Brd | Liver hyperplasia |
|
Liver |
observed |
|
| C57BL/6 | Ovary - Granulosa cell tumor | Ovary - Granulosa cell |
0 |
||
| C57BL/6 | Ovary - Granulosa cell tumor |
|
Ovary - Granulosa cell |
1.14 |
|
| C57BL/6 | Ovary - Granulosa cell tumor |
|
Ovary - Granulosa cell |
3.7 |
|
| B6.129-Bmal1tm1Bra/+ | Ovary - Granulosa cell tumor | Ovary - Granulosa cell |
3.23 |
||
| B6.129-Bmal1tm1Bra/+ | Ovary - Granulosa cell tumor |
|
Ovary - Granulosa cell |
3.7 |
|
| B6.129-Bmal1tm1Bra | Ovary - Granulosa cell tumor | Ovary - Granulosa cell |
0 |
||
| B6.129-Bmal1tm1Bra | Ovary - Granulosa cell tumor |
|
Ovary - Granulosa cell |
0 |
|
| B6.129-Bmal1tm1Bra | Ovary - Granulosa cell tumor |
|
Ovary - Granulosa cell |
0 |
|
| B6.129-Per2tm1Ccl | Ovary - Granulosa cell tumor | Ovary - Granulosa cell |
3.33 |
||
| B6.129-Per2tm1Ccl | Ovary - Granulosa cell tumor |
|
Ovary - Granulosa cell |
6.06 |
|
| B6.129-Per2tm1Ccl | Ovary - Granulosa cell tumor |
|
Ovary - Granulosa cell |
8.57 |
|
| C57BL/6-Cry1tm1Asn | Ovary - Granulosa cell tumor | Ovary - Granulosa cell |
5.0 |
||
| C57BL/6-Cry1tm1Asn | Ovary - Granulosa cell tumor |
|
Ovary - Granulosa cell |
9.52 |
|
| C57BL/6-Cry1tm1Asn Cry2tm1Asn | Ovary - Granulosa cell tumor | Ovary - Granulosa cell |
3.33 |
||
| C57BL/6-Cry1tm1Asn Cry2tm1Asn | Ovary - Granulosa cell tumor |
|
Ovary - Granulosa cell |
6.67 |
|
| C57BL/6-Cry1tm1Asn Cry2tm1Asn | Ovary - Granulosa cell tumor |
|
Ovary - Granulosa cell |
9.09 |
|
| C57BL/6-Per1tm1Brd Per2tm1Brd | Ovary - Granulosa cell tumor | Ovary - Granulosa cell |
2.5 |
||
| C57BL/6-Per1tm1Brd Per2tm1Brd | Ovary - Granulosa cell tumor |
|
Ovary - Granulosa cell |
6.38 |
|
| C57BL/6-Per1tm1Brd Per2tm1Brd | Ovary - Granulosa cell tumor |
|
Ovary - Granulosa cell |
10.2 |
|
| C57BL/6-Cry1tm1Asn Cry2tm1Asn | Pancreas tumor |
|
Pancreas |
observed |
|
| C57BL/6-Per1tm1Brd Per2tm1Brd | Pancreas tumor |
|
Pancreas |
observed |
|
| C57BL/6 | Reproductive system (sex not specified) hyperplasia - cystic | Reproductive system (sex not specified) |
6.67 |
||
| C57BL/6 | Reproductive system (sex not specified) hyperplasia - cystic |
|
Reproductive system (sex not specified) |
6.82 |
|
| C57BL/6 | Reproductive system (sex not specified) hyperplasia - cystic |
|
Reproductive system (sex not specified) |
16.67 |
|
| B6.129-Bmal1tm1Bra/+ | Reproductive system (sex not specified) hyperplasia - cystic | Reproductive system (sex not specified) |
12.9 |
||
| B6.129-Bmal1tm1Bra/+ | Reproductive system (sex not specified) hyperplasia - cystic |
|
Reproductive system (sex not specified) |
14.81 |
|
| B6.129-Bmal1tm1Bra | Reproductive system (sex not specified) hyperplasia - cystic | Reproductive system (sex not specified) |
4.35 |
||
| B6.129-Bmal1tm1Bra | Reproductive system (sex not specified) hyperplasia - cystic |
|
Reproductive system (sex not specified) |
0 |
|
| B6.129-Bmal1tm1Bra | Reproductive system (sex not specified) hyperplasia - cystic |
|
Reproductive system (sex not specified) |
0 |
|
| B6.129-Per2tm1Ccl | Reproductive system (sex not specified) hyperplasia - cystic | Reproductive system (sex not specified) |
13.33 |
||
| B6.129-Per2tm1Ccl | Reproductive system (sex not specified) hyperplasia - cystic |
|
Reproductive system (sex not specified) |
12.12 |
|
| B6.129-Per2tm1Ccl | Reproductive system (sex not specified) hyperplasia - cystic |
|
Reproductive system (sex not specified) |
20 |
|
| C57BL/6-Cry1tm1Asn | Reproductive system (sex not specified) hyperplasia - cystic | Reproductive system (sex not specified) |
15 |
||
| C57BL/6-Cry1tm1Asn | Reproductive system (sex not specified) hyperplasia - cystic |
|
Reproductive system (sex not specified) |
14.29 |
|
| C57BL/6-Cry1tm1Asn Cry2tm1Asn | Reproductive system (sex not specified) hyperplasia - cystic | Reproductive system (sex not specified) |
20 |
||
| C57BL/6-Cry1tm1Asn Cry2tm1Asn | Reproductive system (sex not specified) hyperplasia - cystic |
|
Reproductive system (sex not specified) |
20 |
|
| C57BL/6-Cry1tm1Asn Cry2tm1Asn | Reproductive system (sex not specified) hyperplasia - cystic |
|
Reproductive system (sex not specified) |
30.3 |
|
| C57BL/6-Per1tm1Brd Per2tm1Brd | Reproductive system (sex not specified) hyperplasia - cystic | Reproductive system (sex not specified) |
10 |
||
| C57BL/6-Per1tm1Brd Per2tm1Brd | Reproductive system (sex not specified) hyperplasia - cystic |
|
Reproductive system (sex not specified) |
17.02 |
|
| C57BL/6-Per1tm1Brd Per2tm1Brd | Reproductive system (sex not specified) hyperplasia - cystic |
|
Reproductive system (sex not specified) |
28.57 |
|
| C57BL/6 | Salivary gland hyperplasia | Salivary gland |
10.0 - 15.0 |
||
| B6.129S7-Trp53tm1Brd | Salivary gland hyperplasia |
|
Salivary gland |
observed |
|
| C57BL/6-Cry1tm1Asn Cry2tm1Asn | Seminal vesicle hyperplasia - cystic |
|
Seminal vesicle |
observed |
|
| C57BL/6-Per1tm1Brd Per2tm1Brd | Seminal vesicle hyperplasia - cystic |
|
Seminal vesicle |
observed |
|
| C57BL/6 | Uterus hyperplasia - cystic |
|
Uterus |
observed |
|
| B6.129-Per2tm1Ccl | Uterus hyperplasia - cystic | Uterus |
observed |
||
| C57BL/6-Cry1tm1Asn Cry2tm1Asn | Uterus hyperplasia - cystic | Uterus |
observed |
||
| C57BL/6-Cry1tm1Asn Cry2tm1Asn | Uterus hyperplasia - cystic |
|
Uterus |
observed |
|
| C57BL/6-Per1tm1Brd Per2tm1Brd | Uterus hyperplasia - cystic | Uterus |
observed |
||
| C57BL/6-Per1tm1Brd Per2tm1Brd | Uterus hyperplasia - cystic |
|
Uterus |
observed |
|
| C57BL/6 | (Unspecified organ) angiosarcoma | (Unspecified organ) |
2.22 |
||
| C57BL/6 | (Unspecified organ) angiosarcoma |
|
(Unspecified organ) |
4.55 |
|
| C57BL/6 | (Unspecified organ) angiosarcoma |
|
(Unspecified organ) |
3.7 |
|
| B6.129-Bmal1tm1Bra/+ | (Unspecified organ) angiosarcoma | (Unspecified organ) |
0 |
||
| B6.129-Bmal1tm1Bra/+ | (Unspecified organ) angiosarcoma |
|
(Unspecified organ) |
0 |
|
| B6.129-Bmal1tm1Bra | (Unspecified organ) angiosarcoma | (Unspecified organ) |
0 |
||
| B6.129-Bmal1tm1Bra | (Unspecified organ) angiosarcoma |
|
(Unspecified organ) |
0 |
|
| B6.129-Bmal1tm1Bra | (Unspecified organ) angiosarcoma |
|
(Unspecified organ) |
0 |
|
| B6.129-Per2tm1Ccl | (Unspecified organ) angiosarcoma | (Unspecified organ) |
0 |
||
| B6.129-Per2tm1Ccl | (Unspecified organ) angiosarcoma |
|
(Unspecified organ) |
0 |
|
| B6.129-Per2tm1Ccl | (Unspecified organ) angiosarcoma |
|
(Unspecified organ) |
0 |
|
| C57BL/6-Cry1tm1Asn | (Unspecified organ) angiosarcoma | (Unspecified organ) |
0 |
||
| C57BL/6-Cry1tm1Asn | (Unspecified organ) angiosarcoma |
|
(Unspecified organ) |
0 |
|
| C57BL/6-Cry1tm1Asn Cry2tm1Asn | (Unspecified organ) angiosarcoma | (Unspecified organ) |
0 |
||
| C57BL/6-Cry1tm1Asn Cry2tm1Asn | (Unspecified organ) angiosarcoma |
|
(Unspecified organ) |
0 |
|
| C57BL/6-Cry1tm1Asn Cry2tm1Asn | (Unspecified organ) angiosarcoma |
|
(Unspecified organ) |
3.03 |
|
| C57BL/6-Per1tm1Brd Per2tm1Brd | (Unspecified organ) angiosarcoma | (Unspecified organ) |
0 |
||
| C57BL/6-Per1tm1Brd Per2tm1Brd | (Unspecified organ) angiosarcoma |
|
(Unspecified organ) |
0 |
|
| C57BL/6-Per1tm1Brd Per2tm1Brd | (Unspecified organ) angiosarcoma |
|
(Unspecified organ) |
0 |